For example, The Aβ25−35-induced mouse model of AD displayed pathologic weight loss, decreased energy expenditure, deregulated insulin secretion and elevated HOMA-IR scores, which signified the presence of peripheral insulin resistance, whereas centrally administered AG restored these metabolic alterations. This evidence concerns the gene INS and Insulin resistance.